licensedpsychedelics

Independent comparison

Joyous vs Mindbloom

Side-by-side analysis from the LicensedPsychedelics editorial team. Neither program pays for placement; we have no affiliate relationship with either at the time this page was published. Updated 2026-04-29.

Joyous

$

Cheap, daily, low-dose. Closer to an SSRI workflow than psychedelic therapy.

Model

Daily microdose

Therapy

asynchronous app

Founded

2022

Research

None published

Editorial verdict

Best fit if cost is the binding constraint or you want a daily ketamine adjunct to an SSRI/SNRI rather than a session-based therapy. Not a substitute for in-clinic ketamine if you have severe TRD.

joyous.team

Mindbloom

$$$

The most clinically structured at-home ketamine program in the US.

Model

Structured 6-session program

Therapy

coach + groups

Founded

2018

Research

Peer-reviewed

Editorial verdict

If you can afford it and have someone who can sit with you, Mindbloom is the most defensible at-home option clinically. If either constraint fails, look at Innerwell or Better U.

www.mindbloom.com

Side-by-side

Attribute
Joyous
Mindbloom
Dosing model
Daily microdose
Structured 6-session program
Route of administration
sublingual lozenge
sublingual lozenge
Pricing
$129/month flat. No tier-up. No therapy bundle.
From $193/month for the standard 6-session program. Add-ons: deep-dive coaching $99/session, group integration included.
Price band
$
$$$
Therapy support
asynchronous app
coach + groups
Insurance
Self-pay; HSA/FSA eligible.
Self-pay; HSA/FSA eligible.
State availability
33+ states (one of the wider at-home networks).
37 states (most populous; check state list at booking).
Founded
2022
2018
Headquarters
Austin, TX
New York, NY
Peer-reviewed outcomes
No
Yes

What Joyous actually is

Joyous is a daily-microdose at-home ketamine program. Patients take a small sublingual lozenge most days, without a structured session, monitor, or sitter. The model is closest to a daily antidepressant: subtle, cumulative, low-intensity. Support is asynchronous via app and text. There is no published outcomes research on the Joyous protocol, and the daily-low-dose approach is not the format most ketamine clinical research has tested.

What to watch for

No peer-reviewed outcomes on the daily-microdose model. Most published ketamine literature is on session-based dosing - extrapolating to daily microdosing is a clinical assumption, not an established protocol.

Best fit

Patients who want the cheapest, lowest-friction at-home access, and who do not want a structured psychedelic experience.

What Mindbloom actually is

Mindbloom is the longest-running and largest at-home ketamine telehealth program in the US, with more than 600,000 sessions delivered since 2018. Patients are prescribed sublingual ketamine lozenges, paired with a structured 6-session program over 8 weeks, a peer monitor on the day of dosing, and 1:1 coaching plus integration groups. Mindbloom is the only at-home ketamine provider that has published peer-reviewed outcomes data on its own protocol.

What to watch for

More expensive than competitors. Requires a peer monitor on dosing days, which is non-negotiable - some patients find this logistically hard.

Best fit

Patients who want the most clinically structured, evidence-backed at-home option and are willing to pay for it.

Common questions

What is the main difference between Joyous and Mindbloom?

Joyous is a daily microdose ($ price band, asynchronous app support). Mindbloom is a structured 6-session program ($$$ price band, coach + groups support). The biggest practical differences are pricing, the level of clinical support, and whether the program is session-based or daily.

Is Joyous or Mindbloom cheaper?

Joyous is the cheaper option ($ band: $129/month flat. No tier-up. No therapy bundle.). Mindbloom is in the $$$ band: From $193/month for the standard 6-session program. Add-ons: deep-dive coaching $99/session, group integration included..

Does Joyous or Mindbloom accept insurance?

Joyous: Self-pay; HSA/FSA eligible. Mindbloom: Self-pay; HSA/FSA eligible.

Which has more clinical research backing?

Mindbloom has published peer-reviewed outcomes data on its protocol; Joyous has not. Among the major at-home ketamine telehealth programs, only Mindbloom has done this so far.

Should I do at-home ketamine therapy or go to a clinic?

If you have severe or treatment-resistant depression with safety concerns, in-clinic IV ketamine has the strongest clinical evidence. If you have moderate depression and want a structured therapeutic experience at lower cost, at-home programs like Joyous or Mindbloom can be appropriate. The decisive factors are: clinical severity, support system at home, and whether your insurance covers Spravato (which would make Spravato the cheapest option for you).

Compare other at-home ketamine programs